RAGGI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 3.114
AS - Asia 2.638
EU - Europa 2.126
SA - Sud America 377
AF - Africa 49
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.337
Nazione #
US - Stati Uniti d'America 3.067
RU - Federazione Russa 965
CN - Cina 810
SG - Singapore 743
IT - Italia 346
HK - Hong Kong 300
BR - Brasile 298
KR - Corea 267
VN - Vietnam 230
IE - Irlanda 173
PL - Polonia 147
SE - Svezia 132
IN - India 89
FR - Francia 83
DE - Germania 75
FI - Finlandia 61
GB - Regno Unito 37
AR - Argentina 36
ID - Indonesia 33
AU - Australia 31
JP - Giappone 27
JO - Giordania 22
NL - Olanda 22
CA - Canada 19
EC - Ecuador 19
IQ - Iraq 17
ES - Italia 12
TR - Turchia 12
UA - Ucraina 12
BD - Bangladesh 11
TW - Taiwan 11
ZA - Sudafrica 11
MK - Macedonia 10
AT - Austria 9
CH - Svizzera 9
MX - Messico 9
PH - Filippine 9
NG - Nigeria 8
IR - Iran 7
KZ - Kazakistan 7
CI - Costa d'Avorio 6
CO - Colombia 6
EG - Egitto 6
PK - Pakistan 6
CL - Cile 5
LK - Sri Lanka 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BJ - Benin 4
JM - Giamaica 4
KE - Kenya 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
TH - Thailandia 4
BO - Bolivia 3
CR - Costa Rica 3
EE - Estonia 3
LB - Libano 3
OM - Oman 3
RO - Romania 3
RS - Serbia 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BE - Belgio 2
HU - Ungheria 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
SN - Senegal 2
UY - Uruguay 2
VE - Venezuela 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
LV - Lettonia 1
ME - Montenegro 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 8.332
Città #
Santa Clara 1.029
Singapore 590
Ashburn 437
Hefei 285
Seoul 265
Hong Kong 246
Dublin 172
San Jose 154
Warsaw 147
Fairfield 116
Florence 91
Chandler 86
Beijing 83
Ho Chi Minh City 65
Los Angeles 63
Altamura 62
Hanoi 62
Lawrence 62
Moscow 57
Houston 55
Seattle 51
Lauterbourg 50
Kent 48
The Dalles 48
Buffalo 47
Cambridge 39
Wilmington 38
Woodbridge 37
Princeton 32
Dallas 31
Melbourne 31
Boston 30
Helsinki 30
Council Bluffs 29
Rome 25
Munich 24
São Paulo 24
Milan 23
Mumbai 23
Tokyo 23
New York 22
Shanghai 22
Jakarta 21
Bengaluru 19
San Diego 18
Ann Arbor 17
Turku 16
West Jordan 16
Paris 15
Frankfurt am Main 14
Lappeenranta 14
Chicago 13
Atlanta 12
Falkenstein 11
Da Nang 10
Dong Ket 10
Guangzhou 10
London 10
Guayaquil 9
Haiphong 9
Abuja 8
Belo Horizonte 8
Medford 8
Modena 8
Rio de Janeiro 8
Istanbul 7
Orem 7
Phoenix 7
San Francisco 7
Abidjan 6
Baghdad 6
Boardman 6
Cairo 6
Curitiba 6
Naples 6
Pune 6
Quito 6
Amsterdam 5
Clifton 5
Colombo 5
Fortaleza 5
Hangzhou 5
Montreal 5
Shenzhen 5
Turin 5
Zurich 5
Almaty 4
Baku 4
Bern 4
Biella 4
Brasília 4
Brooklyn 4
Bắc Ninh 4
Chennai 4
Cisano Bergamasco 4
Columbus 4
Cotonou 4
Hillsboro 4
Isidro Casanova 4
Kolkata 4
Totale 5.315
Nome #
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 327
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 230
Organoids and spheroids: advanced in vitro models for liver cancer research. 204
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 202
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 202
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 194
Fatty acids regulate the biology of cholangiocarcinoma cells 191
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 187
The role of stroma in cholangiocarcinoma: The intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium 186
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 186
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 180
Role of chemokines in the biology of cholangiocarcinoma 179
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 177
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 176
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 176
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives 166
Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16 164
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 161
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 159
Metabolic reprogramming in cholangiocarcinoma 155
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma 143
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 143
3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma Cells 140
A novel multidrug‐resistant cell line from an italian intrahepatic cholangiocarcinoma patient 140
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells 140
The role of the hedgehog pathway in cholangiocarcinoma 138
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 134
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma 131
Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 131
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. 127
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2 122
Assessment of a high sensitivity method for identification of IDH1 R132x mutations in tumors and plasma of Intrahepatic Cholangiocarcinoma patients 122
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line resistant to gemcitabine 117
Epigenetic reprogramming modulates malignant properties of human liver cancer 114
An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer. 113
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer 112
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages 110
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the β-cell line INS-1E 110
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus. 109
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. 109
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types 109
RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines 108
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts 107
Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity 107
Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. 106
More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma 106
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 104
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 104
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma 104
Mesenchymal stem cells, aging and regenerative medicine. 102
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma 101
Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 100
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma 98
Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 98
Iron metabolism in liver cancer stem cells 94
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 93
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. 92
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 91
Methylation and liver cancer 85
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies 75
The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma 59
A novel naphthoquinone compound triggers DNA damage-induced apoptosis on cholangiocarcinoma through upregulation of BAX 52
Cholangiocarcinoma 2026: status quo, unmet needs and priorities. 28
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome 27
Totale 8.457
Categoria #
all - tutte 23.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 21 23
2021/2022258 27 2 3 8 4 15 1 17 63 15 28 75
2022/2023613 62 166 51 16 14 105 84 37 52 4 12 10
2023/2024422 11 30 41 30 31 40 19 101 16 35 60 8
2024/20252.970 69 277 145 430 878 352 135 77 156 81 138 232
2025/20263.616 411 566 545 456 347 127 429 180 194 248 113 0
Totale 8.457